Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBanco Santander Regulatory News (BNC)

Share Price Information for Banco Santander (BNC)

Share Price is delayed by 15 minutes
Get Live Data
1,022.00    6.00 (0.59%)
Bid:
1,026.00
Ask:
1,030.00
Spread: 4.00 (0.39%)
Market Cap: £146.52b
BNC Live PriceLast checked at - London Stock Exchange

Intraday Banco Santander Share Chart

Share capital increase

4 Jul 2017 07:00

RNS Number : 0001K
Banco Santander S.A.
03 July 2017
 

 

 

 

 

 

MATERIAL FACT

 

 

Following the material fact of 7 June 2017 (registration number 252,990), Banco Santander, S.A. ("Banco Santander" or the "Bank") informs that its executive committee, acting under the authorization granted to the board of directors by the general shareholders' meeting held on 7 April 2017 under item five of the agenda and the subsequent delegation of powers approved by the Bank's board of directors in favour of the abovementioned executive committee, has agreed to increase Banco Santander's share capital by a nominal amount of EUR 729,116,372.50 by issuing 1,458,232,745 new ordinary shares, of the same class and series as the shares currently outstanding, and with pre-emptive subscription rights for shareholders (the "Capital Increase" or the "Increase").

 

The issue of new shares will be carried out at their nominal value of fifty euro cents (0.50 €) plus an issue premium of EUR 4.35 per share, so that the total value of the issuance of new shares is EUR 4.85 per share and the total effective amount of the Capital Increase (including nominal value and issue premium) is EUR 7,072,428,813.25. The Increase aims to reinforce and optimize the Bank's equity structure to adequately cover the acquisition of 100% of Banco Popular Español, S.A.'s share capital.

 

Each outstanding share grants its holder a pre-emptive subscription right, and 10 pre-emptive subscription rights are required to subscribe 1 new share. Once the relevant prospectus has been registered with the Spanish Securities Market Commission ("CNMV"), the Increase will be officially communicated by publication in the Official Gazette of the Commercial Registry and, after that, the period to exercise pre-emptive subscription rights will commence, lasting 15 calendar days as from the day immediately following the publication date of the announcement. It is estimated that the pre-emptive subscription rights period commences on 6 July and ends on 20 July (both inclusive). Pre-emptive subscription rights are expected to be listed on the Spanish stock exchanges and the stock exchanges of Lisbon and Buenos Aires. Any pre-emptive subscription rights that are not exercised will automatically expire at the end of the pre-emptive subscription right subscription period.

 

Shareholders with pre-emptive subscription rights and investors or shareholders who acquire them in the market, may request to subscribe a number of additional shares besides those to which they are entitled by exercising their rights, if the Capital Increase is not fully subscribed in the pre-emptive subscription rights subscription period and as long as both investors and shareholders have exercised all their pre-emptive subscription rights. In addition, if requests for additional shares are insufficient to cover the Capital Increase, the remaining new shares may be discretionally allotted to investors.[1] The newly issued shares in the Capital Increase are expected to grant a share in the first interim dividend charged against the results of the 2017 financial year.

 

Banco Santander has entered into an underwriting agreement, for the entire Capital Increase, with a syndicate of credit entities, under which the Increase is fully underwritten. Banco Santander, Citigroup Global Markets Limited and UBS Limited will act as joint global coordinators of the Capital Increase.

 

The terms and conditions of the Capital Increase and the procedure to subscribe new shares in Spain, the United Kingdom, Portugal, Italy and Poland are set out in a prospectus to be registered with the CNMV. Once registered with the CNMV, the prospectus will be publicly available at the Bank's registered address and, in electronic format, in the web pages of the Bank (www.santander.com) and the CNMV (www.cnmv.es).

 

Boadilla del Monte (Madrid), 3 July, 2017

______________________________________________________________________

 

IMPORTANT INFORMATION

 

This document is not an informative prospectus but an informative communication and investors should not subscribe any new shares of Banco Santander, S.A. ("Banco Santander" or the "Bank") or purchase any pre-emptive subscription rights for new shares of the Bank's Capital Increase referred to in this document except on the basis of the information contained in the prospectus of the rights issue which Banco Santander will register with the Comisión Nacional del Mercado de Valores ("CNMV"). Once registered with the CNMV, the prospectus will be publicly available at the Bank's registered address and, in electronic format, in the web pages of the Bank (www.santander.com) and the CNMV (www.cnmv.es). The Bank expects to request the CNMV to passport the prospectus of the rights issue, once approved and registered, for the purposes of it being effective in the United Kingdom, Italy, Portugal and Poland.

 

This announcement does not constitute an offer to sell, or a solicitation of offers to subscribe, the pre-emptive subscription rights or the new shares of the share capital increase, in any jurisdiction in which such offer or solicitation is unlawful or, as the case may be, until the applicable requirements for those purposes have been met. The distribution of this announcement and/or the prospectus and/or the transfer of pre-emptive subscription rights and/or new shares into jurisdictions other than Spain, the United Kingdom, Italy, Portugal and Poland may be restricted by law. Persons who gain access to this announcement should be aware of and comply with any such restrictions. Any failure to comply with them may constitute a breach of the securities laws of any such jurisdiction.

 

This communication (i) must not be construed in any way to be a request to buy or to sell securities or any related financial instruments in Brazil, and (ii) must not be construed in any way to be a public offering of securities in Brazil. The Brazilian Securities Commission (Comissão de Valores Mobiliários) has not authorised the public offering of shares to which this communication refers nor of any securities related to such shares. Hence, the said shares cannot be offered to the public in Brazil.

 

The Bank has filed a registration statement (including a prospectus) with the SEC for the capital increase and the offering of new shares and subscription rights to which this communication relates. Before you invest, you should read the prospectus in that registration statement and other documents the Bank has filed with the SEC for more complete information about the issuer and this offering. You may get these documents for free by visiting EDGAR on the SEC Web site at www.sec.gov. Alternatively, you may obtain a copy of the prospectus from Citigroup by calling toll free 1-800-831-9146 or UBS by calling toll free 1-877-387-2275.

 

Authorisation for the public offering of the new Banco Santander shares and their admission to trading in the Buenos Aires stock exchange will be requested to the Argentine National Securities Commission. Once such authorisation is granted, a Subscription Announcement will be published in Argentina setting out the procedure and term to subscribe new shares in Argentina. The capital increase to which this announcement refers and the Argentine offering will have the same terms and conditions, save as otherwise provided in the relevant Subscription Announcement.

 


[1] The procedure for the subscription of the new shares may differ for investors who hold Banco Santander's shares in the different foreign stock exchanges in which the Bank's shares are listed.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCOKNDQKBKBNOK
Date   Source Headline
27th Sep 20237:00 amRNSFurther re dividend approval
27th Sep 20237:00 amRNSDividend approval & buyback program implementation
19th Sep 20237:00 amRNSSantander aligns several models to its strategy
18th Sep 20235:14 pmRNSPerpetual Preferred Securities: rate replacement
31st Aug 20233:09 pmRNSTotal Voting Rights
31st Jul 20232:35 pmRNSTotal Voting Rights
28th Jul 20235:35 pmRNSStress Test Results
28th Jul 202312:56 pmRNSHalf-year Report
26th Jul 20237:00 amRNS1H2023 Results - Press release
26th Jul 20237:00 amRNS1H2023 Results Report & Earnings Presentation
19th Jul 202311:52 amRNSNotice of First Half 2023 Results
30th Jun 20233:28 pmRNSFurther re capital reduction
30th Jun 20232:23 pmRNSTotal Voting Rights
27th Jun 20236:07 pmRNSTotal Voting Rights
27th Jun 20236:03 pmRNSCapital reduction (buy-back programme shares)
31st May 202312:19 pmRNSTotal Voting Rights
19th May 202310:51 amRNSDirector/PDMR Shareholding
18th May 20235:20 pmRNSSantander informs of the MREL determined by SRB
3rd May 202311:38 amRNSCovered Bonds: interest rate replacement
28th Apr 202311:39 amRNSTotal Voting Rights
28th Apr 202311:24 amRNSDirector/PDMR Shareholding
25th Apr 20237:00 amRNS1Q2023 Results - Press release
25th Apr 20237:00 amRNS1Q2023 Financial report & Earnings presentation
24th Apr 20237:00 amRNSEnd of the Programme & 19-21 April Transactions
19th Apr 202311:22 amRNSBuyback programme: transactions 12 - 18 April
18th Apr 202311:26 amRNSNotice of First Quarter 2023 Results
12th Apr 202311:04 amRNSBuyback programme: transactions 30 March -11 April
11th Apr 20237:00 amRNSFurther re Santander Mexico tender offer: results
31st Mar 20232:28 pmRNS2023 AGM - Resolutions
31st Mar 202312:11 pmRNSTotal Voting Rights
31st Mar 20237:35 amRNSSantander to confirm its targets for 2023 at AGM
30th Mar 202311:05 amRNSBuyback programme: transactions 23 - 29 March
23rd Mar 202311:40 amRNSDirector/PDMR Shareholding
23rd Mar 202310:22 amRNSBuyback programme: transactions 16 - 22 March
21st Mar 20231:04 pmRNSFurther re capital reduction
17th Mar 202312:21 pmRNSDirector/PDMR Shareholding
16th Mar 20235:16 pmRNSTotal Voting Rights
16th Mar 202311:18 amRNSCapital reduction (buy-back programme shares)
16th Mar 202311:09 amRNSBuyback programme: transactions 9 - 15 March
10th Mar 20239:55 amRNS2022 UK Annual Report
9th Mar 20234:27 pmRNSDirector/PDMR Shareholding
9th Mar 202311:39 amRNSBuyback programme: transactions 1 - 8 March
6th Mar 20233:02 pmRNSDirector/PDMR Shareholding
6th Mar 20232:59 pmRNSDirector/PDMR Shareholding
28th Feb 20235:27 pmRNSNotice of AGM
28th Feb 202312:23 pmRNSTotal Voting Rights
28th Feb 20239:51 amRNSInvestor Day: Group CFO presentation
28th Feb 20238:33 amRNSInvestor Day: Group CEO presentation
28th Feb 20238:05 amRNSInvestor Day: Executive chair presentation
28th Feb 20237:00 amRNSPayout policy, strategic plans & profit forecasts

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.